Beactica Therapeutics AB
556708-2853ActivePrecision medicine company developing novel therapeutics via targeted protein degradation.
Biotechnology Companybeactica.com
Overview
- 5–9
- Employees
- 5–10M SEK
- Revenue
- 2006
- Founded
Key Decision Makers
Per Källblad
Chief Executive Officer
Description
Beactica Therapeutics is a precision medicine company focused on developing novel small molecule therapeutics for life-threatening diseases with significant unmet clinical needs. The company leverages its proprietary Eclipsor™ platform, which synergizes allosteric modulation and Targeted Protein Deg...
Tags
B2BPharmaceuticals